• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.阿戈美拉汀在无定形固体分散体中的稳定性。 (注:原文中药物名称有误,正确的应该是“阿戈美拉汀”,而不是“佐匹克隆”,按照正确药物名翻译后的内容。如果按照错误药物名翻译就是:佐匹克隆在无定形固体分散体中的稳定性 )
AAPS PharmSciTech. 2015 Oct;16(5):1190-202. doi: 10.1208/s12249-015-0302-4. Epub 2015 Mar 4.
2
Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.无定形磺胺多辛:物理稳定性及结晶动力学研究
AAPS PharmSciTech. 2016 Oct;17(5):1100-9. doi: 10.1208/s12249-015-0436-4. Epub 2015 Nov 3.
3
Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.吲哚美辛/PVP固体分散体肠溶微粒的拉曼光谱与热分析
Eur J Pharm Biopharm. 2008 Sep;70(1):409-20. doi: 10.1016/j.ejpb.2008.03.016. Epub 2008 Apr 8.
4
Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.固体分散体法对他克莫司溶解度和结晶性质的影响。
Int J Pharm. 2010 Aug 16;395(1-2):161-6. doi: 10.1016/j.ijpharm.2010.05.023. Epub 2010 May 24.
5
Characterization of zopiclone crystal forms found among generic raw materials.仿制药原料中佐匹克隆晶型的表征
Drug Dev Ind Pharm. 2000 May;26(5):531-7. doi: 10.1081/ddc-100101264.
6
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
7
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
8
Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.通过在弱有机酸浓水溶液中增溶并干燥制备的伊曲康唑固体分散体的表征
Pharm Res. 2016 Jun;33(6):1456-71. doi: 10.1007/s11095-016-1890-8. Epub 2016 Mar 7.
9
Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.使用喷雾干燥机制备的塞来昔布在PVP/异麦芽酮糖醇固体分散体中的异常溶解行为。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14.
10
Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.含储存和压缩稳定剂的无定形塞来昔布喷雾干燥共沉淀物的研制
Acta Pharm. 2007 Sep;57(3):287-300. doi: 10.2478/v10007-007-0023-7.

引用本文的文献

1
Advances in the development of amorphous solid dispersions: The role of polymeric carriers.非晶态固体分散体的发展进展:聚合物载体的作用。
Asian J Pharm Sci. 2023 Jul;18(4):100834. doi: 10.1016/j.ajps.2023.100834. Epub 2023 Aug 1.
2
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
3
Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology.固体分散技术中广泛应用的高分子载体概述。
AAPS PharmSciTech. 2020 Nov 8;21(8):309. doi: 10.1208/s12249-020-01849-z.
4
Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.基于聚乙烯吡咯烷酮和羟丙基甲基纤维素的无定形固体分散体的热加工
AAPS PharmSciTech. 2016 Feb;17(1):120-32. doi: 10.1208/s12249-015-0417-7. Epub 2015 Oct 13.

本文引用的文献

1
Fundamental aspects of solid dispersion technology for poorly soluble drugs.难溶性药物固体分散技术的基本方面。
Acta Pharm Sin B. 2014 Feb;4(1):18-25. doi: 10.1016/j.apsb.2013.11.001. Epub 2013 Dec 5.
2
Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.无定形固体分散体和纳米晶体技术在难溶性药物传递中的应用。
Int J Pharm. 2013 Aug 30;453(1):157-66. doi: 10.1016/j.ijpharm.2013.05.061. Epub 2013 Jun 7.
3
Solution-mediated phase transformation of different roxithromycin solid-state forms: Implications on dissolution and solubility.不同罗红霉素固态形式的溶液介导的相转变:对溶解和溶解度的影响。
Int J Pharm. 2013 Jun 5;449(1-2):18-27. doi: 10.1016/j.ijpharm.2013.03.048. Epub 2013 Apr 8.
4
Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.理解原料药的成玻璃能力,用于设计超饱和剂型。
J Pharm Sci. 2012 Sep;101(9):3239-48. doi: 10.1002/jps.23166. Epub 2012 Apr 24.
5
Physicochemical properties of amorphous roxithromycin prepared by quench cooling of the melt or desolvation of a chloroform solvate.熔融淬火或氯仿溶剂化物去溶剂化制备无定形罗红霉素的物理化学性质。
AAPS PharmSciTech. 2012 Jun;13(2):467-76. doi: 10.1208/s12249-012-9766-7. Epub 2012 Mar 6.
6
Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.溶液介导的相转变:在溶解过程中的意义及其对生物利用度的影响。
J Pharm Sci. 2012 Sep;101(9):2996-3018. doi: 10.1002/jps.23025. Epub 2011 Dec 27.
7
Dynamics of ribavirin glass in the sub-Tg temperature region.在亚玻璃化温度区域利巴韦林玻璃的动力学。
J Phys Chem B. 2011 Oct 6;115(39):11375-81. doi: 10.1021/jp2018499. Epub 2011 Sep 13.
8
A classification system to assess the crystallization tendency of organic molecules from undercooled melts.一种评估有机分子从过冷熔体中结晶倾向的分类系统。
J Pharm Sci. 2010 Sep;99(9):3787-806. doi: 10.1002/jps.22197.
9
Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.利用实验测定的相互作用参数估算药物与聚合物在无定形固体分散体中的混溶性和溶解度。
Pharm Res. 2009 Jan;26(1):139-51. doi: 10.1007/s11095-008-9721-1. Epub 2008 Sep 9.
10
Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.由聚乙烯吡咯烷酮VA64、聚山梨酯52和伊曲康唑组成的三元固体分散体的固态特性
Int J Pharm. 2005 Oct 13;303(1-2):54-61. doi: 10.1016/j.ijpharm.2005.07.002.

阿戈美拉汀在无定形固体分散体中的稳定性。 (注:原文中药物名称有误,正确的应该是“阿戈美拉汀”,而不是“佐匹克隆”,按照正确药物名翻译后的内容。如果按照错误药物名翻译就是:佐匹克隆在无定形固体分散体中的稳定性 )

The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.

作者信息

Milne Marnus, Liebenberg Wilna, Aucamp Marique

机构信息

Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, Potchefstroom Campus, North-West University, 2520, Potchefstroom, South Africa.

出版信息

AAPS PharmSciTech. 2015 Oct;16(5):1190-202. doi: 10.1208/s12249-015-0302-4. Epub 2015 Mar 4.

DOI:10.1208/s12249-015-0302-4
PMID:25732372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4674634/
Abstract

Zopiclone is a poorly soluble psychotherapeutic agent. The aim of this study was to prepare and characterize an amorphous form of zopiclone as well as the characterization and performance of a stable amorphous solid dispersion. The amorphous form was prepared by the well-known method of quench-cooling of the melt. The solid dispersion was prepared by a solvent evaporation method of zopiclone, polyvinylpyrrolidone-25 (PVP-25), and methanol, followed by freeze-drying. The physico-chemical properties and stability of amorphous zopiclone and the solid dispersion was studied using differential scanning calorimetry (DSC), infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), scanning electron microscopy (SEM), hot-stage microscopy (HSM), X-ray diffractometry (XRD), solubility, and dissolution studies. The zopiclone amorphous solid-state form was determined to be a fragile glass; it was concluded that the stability of the amorphous form is influenced by both temperature and water. Exposure of amorphous zopiclone to moisture results in rapid transformation of the amorphous form to the crystalline dihydrated form. In comparison, the amorphous solid dispersion proved to be more stable with increased aqueous solubility.

摘要

佐匹克隆是一种难溶性的精神治疗药物。本研究的目的是制备并表征佐匹克隆的无定形形式以及稳定的无定形固体分散体的表征和性能。无定形形式通过众所周知的熔体骤冷法制备。固体分散体通过佐匹克隆、聚乙烯吡咯烷酮-25(PVP-25)和甲醇的溶剂蒸发法制备,然后进行冷冻干燥。使用差示扫描量热法(DSC)、红外光谱法(FT-IR)、热重分析(TGA)、扫描电子显微镜(SEM)、热台显微镜(HSM)、X射线衍射法(XRD)、溶解度和溶出度研究来研究无定形佐匹克隆和固体分散体的物理化学性质及稳定性。佐匹克隆无定形固态形式被确定为易碎玻璃;得出的结论是,无定形形式的稳定性受温度和水的影响。无定形佐匹克隆暴露于湿气中会导致无定形形式迅速转变为结晶二水合物形式。相比之下,无定形固体分散体被证明更稳定且水溶性增加。